Todd Anderman Ocular Therapeutix, Inc (OCUL) insider trading activity

OCUL Quotes by TradingView

Todd Anderman is Chief Legal Officer of OCULAR THERAPEUTIX, INC. Currently has a direct ownership of 152,468 shares of OCUL, which is worth approximately $1.73 Million. The most recent transaction as insider was on Jan 02, 2026, when has been sold 64,900 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 152K
74.11% 3M change
54.48% 12M change
Total Value Held $1.73 Million

Todd Anderman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 02 2026
BUY
Grant, award, or other acquisition
-
64,900 Added 29.86%
152,468 Common Stock
Oct 08 2025
SELL
Open market or private sale
$137,368 $12.34 p/Share
11,132 Reduced 11.28%
87,568 Common Stock
Oct 07 2024
BUY
Grant, award, or other acquisition
-
98,700 Added 50.0%
98,700 Common Stock
TA

Todd Anderman

Chief Legal Officer
Bedford, MA

Track Institutional and Insider Activities on OCUL

Follow OCULAR THERAPEUTIX, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCUL shares.

Notify only if

Insider Trading

Get notified when an Ocular Therapeutix, Inc insider buys or sells OCUL shares.

Notify only if

News

Receive news related to OCULAR THERAPEUTIX, INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on OCUL